Advanced search
Publication Cover
Cancer Investigation Volume 22, 2004 - Issue 3
Submit an article Journal homepage
304
Views
73
CrossRef citations to date
0
Altmetric
Original Article

A Phase I Trial of Olanzapine (Zyprexa) for the Prevention of Delayed Emesis in Cancer Patients: A Hoosier Oncology Group Study

Steven D. Passik Hoosier Oncology Group, Walther Cancer Institute, 3266 N. Meridian St. #902, Indianapolis, Indiana, 6208, USA; Symptom Management and Palliative Care Program, Division of Hematology & Oncology, Department of Internal Medicine, College of Medicine, Markey Cancer Center, University of Kentucky, 800 Rose St.-CC125, Lexington, Kentucky, 40536-0093, USA
, Ph.D.,
Rudolph M. Navari Hoosier Oncology Group, Walther Cancer Institute, 3266 N. Meridian St. #902, Indianapolis, Indiana, 6208, USA; Northern Indiana Oncology Associates, 720 Cedar St. #210, South Bend, Indiana, 46617, USA
, M.D.,
Sin-Ho Jung Department of Biostatistics and Bioinformatics, Duke University, Durham, North CarolinaUSA
, Ph.D.,
Cindy Nagy Hoosier Oncology Group, Walther Cancer Institute, 3266 N. Meridian St. #902, Indianapolis, Indiana, 6208, USA; Northern Indiana Oncology Associates, 720 Cedar St. #210, South Bend, Indiana, 46617, USA
, R.N.,
Jake Vinson Hoosier Oncology Group, Walther Cancer Institute, 3266 N. Meridian St. #902, Indianapolis, Indiana, 6208, USA
, M.A.,
Kenneth L. Kirsh Symptom Management and Palliative Care Program, Division of Hematology & Oncology, Department of Internal Medicine, College of Medicine, Markey Cancer Center, University of Kentucky, 800 Rose St.-CC125, Lexington, Kentucky, 40536-0093, USA
, Ph.D. &
Patrick Loehrer Hoosier Oncology Group, Walther Cancer Institute, 3266 N. Meridian St. #902, Indianapolis, Indiana, 6208, USA; Indiana University Cancer Center, 535 Barnhill Dr. RT 473, Indianapolis, Indiana, 46202, USA
, M.D. show all
Pages 383-388 | Published online: 18 Aug 2004

References

  • Navari R. M., Madajcwicz S., Anderson N., Tchekmedyian N. S., Whaley W., Garewal H., Beck T. M., Chang A. Y., Greenberg B., Caldwell K. C. Oral ondansetron for the control of cisplatin-induced delayed emesis: a large, multicenter, double-blind, randomized comparative trial of ondansetron versus placebo. J. Clin. Oncol. 1995; 13: 2408–2416, [PUBMED], [INFOTRIEVE]
  • Latreille J., Pater J., Johnston D., Laberge F., Stewart D., Rusthoven J., Hoskins P., Findlay B., McMurtrie E., Yelle L., Williams C., Walde D., Ernst S., Dhaliwal H., Warr D., Shepherd F., Mee D., Nishimura L., Osoba D., Zee B. Use of dexamethasone and granisetron in the control of delayed emesis for patients who receive highly emetogenic chemotherapy. J. Clin. Oncol. 1998; 16: 1174–1178, [PUBMED], [INFOTRIEVE]
  • The Italian Group for Antiemetic Research. Dexamethasone alone or in combination with ondansetron for the prevention of delayed nausea and vomiting induced by chemotherapy. N. Engl. J. Med. 2000; 342: 1554–1559, [CSA], [CROSSREF]
  • Wasserman E., Cuvier C., Lokiec F., Goldwasser F., Kalla S., Mery-Mignard D., Ouldkaci M., Besmaine A., Dupont-Andre G., Mahjoubi M., Marty M., Misset J. L., Cvitkovic E. Combination of oxaliplatin plus irinotecan in patients with gastrointestinal tumors: results of two independent phase I studies with pharmacokinetics. J. Clin. Oncol. 1999; 17: 1751–1759, [PUBMED], [INFOTRIEVE]
  • Passik S. D., Kirsh K. L., Rosenfeld B., McDonald M. V., Theobald D. E. The changeable nature of patients' fears regarding chemotherapy: implications for palliative care. J. Pain Symptom Manag. 2001; 21: 113–120, [CSA], [CROSSREF]
  • Pisters K., Kris M. Treatment-related nausea and vomiting. Principles and Practice of Supportive Oncology, A. Berger. Lippincott-Raven, Philadephia 1998; 165–179
  • Ward S. E., Goldberg N., Miller-McCauley V., Mueller C., Nolan A., Pawlik-Plank D., Robbins A., Stormoen D., Weissman D. E. Patient-related barriers to management of cancer pain. Pain 1993; 52: 319–324, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Passik S. D., Lundberg J., Kirsh K. L., Theobald D., Donaghy K., Holtsclaw E., Cooper M., Dugan W. Clinical note: a pilot exploration of the antiemetic activity of olanzapine (zyprexa) for the relief of nausea in patients with advanced pain and cancer. J. Pain Symptom Manag. 2002; 23: 526–532, [CSA], [CROSSREF]
  • Pirl W. F., Roth A. J. Remission of chemotherapy-induced emesis with concurrent olanzapine treatment: a case report. Psycho-oncology 2000; 9: 84–87, [CSA]
  • Bymaster F., Calligaro D. O., Falcone J. F., Marsh R. D., Moore N. A., Tye N. C., Seeman P., Wong D. T. Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology 1996; 14: 87–96, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Cella D. F., Tulsky D. S., Gray G., Sarafian B., Linn E., Bonomi A., Silberman M., Yellen S. B., Winicour P., Brannon J. The functional assessment of cancer therapy scale: development and validation. J. Clin. Oncol. 1993; 11: 570–579, [PUBMED], [INFOTRIEVE]
  • Trowbridge R., Dugan W., Jay S. J., Littrell D., Casebeer L. L., Edgerton S., Anderson J., O'Toole J. B. Determining the effectiveness of a clinical-practice intervention in improving the control of pain in outpatients with cancer. Acad. Med. 1997; 72: 9
  • Schotte A., Janssen P. F., Gommeren W., Luyten W. H., Van Gompel P., Lesage A. S., De Loore K., Leysen J. E. Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Psychopharmacology 1996; 124: 57–73, [PUBMED], [INFOTRIEVE]
  • Borjeson S., Hursti T. J., Tishelman C., Peterson C., Steineck G. Treatment of nausea and emesis during cancer chemotherapy. Discrepancies between antiemetic effect and well-being. J. Pain Symptom Manag. 2002; 24(3)345–358, [CSA], [CROSSREF]
  • Grunberg S. M. Optimal use of antiemetics in the outpatient setting. Oncology (Huntingt) 2002; 16(10)1401–1407, [CSA]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.